| Primary |
| Schizophrenia |
20.8% |
| Bipolar Disorder |
13.7% |
| Schizoaffective Disorder |
9.7% |
| Psychotic Disorder |
8.8% |
| Agitation |
7.5% |
| Schizophrenia, Paranoid Type |
6.6% |
| Major Depression |
4.9% |
| Depression |
3.5% |
| Anxiety |
3.1% |
| Bipolar I Disorder |
3.1% |
| Insomnia |
3.1% |
| Dementia |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Sleep Disorder |
2.2% |
| Agitated Depression |
1.8% |
| Constipation |
1.8% |
| Pain |
1.8% |
| Dental Caries |
1.3% |
| Aggression |
0.9% |
| Amnesia |
0.9% |
|
| Weight Increased |
27.2% |
| Hospitalisation |
8.8% |
| Off Label Use |
7.2% |
| Death |
6.4% |
| Neuroleptic Malignant Syndrome |
4.8% |
| Overdose |
4.8% |
| Sedation |
4.0% |
| Vomiting |
4.0% |
| Hypersomnia |
3.2% |
| Prescribed Overdose |
3.2% |
| Pulmonary Oedema |
3.2% |
| Tremor |
3.2% |
| White Blood Cell Count Increased |
3.2% |
| Completed Suicide |
2.4% |
| Hypertension |
2.4% |
| Loss Of Consciousness |
2.4% |
| Psychotic Disorder |
2.4% |
| Respiratory Arrest |
2.4% |
| Skin Discolouration |
2.4% |
| Ventricular Tachycardia |
2.4% |
|
| Secondary |
| Schizophrenia |
18.9% |
| Bipolar Disorder |
13.9% |
| Schizoaffective Disorder |
11.3% |
| Schizophrenia, Paranoid Type |
9.6% |
| Depression |
8.3% |
| Agitation |
5.6% |
| Constipation |
3.9% |
| Psychotic Disorder |
3.3% |
| Dementia |
2.9% |
| Pain |
2.8% |
| Product Used For Unknown Indication |
2.7% |
| Hypertension |
2.6% |
| Atrial Fibrillation |
2.5% |
| Anxiety |
2.2% |
| Aggression |
2.0% |
| Major Depression |
1.8% |
| Insomnia |
1.6% |
| Convulsion |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Abnormal Behaviour |
1.3% |
|
| Weight Increased |
34.9% |
| Overdose |
14.6% |
| Diabetes Mellitus |
6.6% |
| Gastric Polyps |
4.0% |
| Off Label Use |
3.3% |
| Psychotic Disorder |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Hypertension |
3.0% |
| Metabolic Syndrome |
3.0% |
| Blood Cholesterol Increased |
2.7% |
| Neuroleptic Malignant Syndrome |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Dizziness |
2.3% |
| Hyperglycaemia |
2.3% |
| Pneumonia |
2.3% |
| Tremor |
2.3% |
| Prescribed Overdose |
2.0% |
| Aspartate Aminotransferase Increased |
1.7% |
| Dyslipidaemia |
1.7% |
| Blood Triglycerides Increased |
1.3% |
|
| Concomitant |
| Schizophrenia |
20.8% |
| Anxiety |
14.5% |
| Depression |
14.5% |
| Insomnia |
6.6% |
| Schizoaffective Disorder |
4.7% |
| Bipolar Disorder |
4.5% |
| Prophylaxis |
4.0% |
| Headache |
3.7% |
| Oral Herpes |
3.7% |
| Affective Disorder |
2.6% |
| Psychotic Disorder |
2.6% |
| Back Pain |
2.4% |
| Drug Dependence |
2.4% |
| Schizophrenia, Paranoid Type |
2.4% |
| Attention Deficit/hyperactivity Disorder |
2.1% |
| Breast Cancer |
2.1% |
| Anxiety Disorder |
1.6% |
| Eczema |
1.6% |
| Hepatitis C |
1.6% |
| Hypertension |
1.6% |
|
| Insomnia |
28.6% |
| Psychotic Disorder |
9.1% |
| Somnolence |
7.8% |
| Tremor |
5.2% |
| Type 2 Diabetes Mellitus |
5.2% |
| Drug Administration Error |
3.9% |
| Granulocytopenia |
3.9% |
| Neutropenia |
3.9% |
| Paraesthesia |
3.9% |
| Pneumonia |
3.9% |
| Post Procedural Complication |
3.9% |
| Swollen Tongue |
3.9% |
| Cardiac Arrest |
2.6% |
| Death |
2.6% |
| Delusion |
2.6% |
| Malaise |
2.6% |
| Proctalgia |
2.6% |
| Abnormal Behaviour |
1.3% |
| Acne Pustular |
1.3% |
| Anaphylactic Shock |
1.3% |
|
| Interacting |
|
|
